Project Number 5R01AT006816-05 Agency/Funding Organization NCCIH Funding Year 2015 View Full Project Details for PRECLINICAL PHARMACOGENOMICS AND SYNAPTIC BIOMARKERS FOR ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) c. ApoE, Lipids and Lipoprotein Receptors Researcher and Organization Principal Investigator COLE, GREGORY M Principal Investigator First Name GREGORY M Principal Investigator Last Name COLE Awardee Organization UNIVERSITY OF CALIFORNIA LOS ANGELES Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA-10-067: RESEARCH PROJECT GRANT (PARENT R01) FY Overall Cost $369,715 Funding Organization Agency/Funding Organization NCCIH Funding Organization Country United States Program Official WILLIAMSON, JOHN S Related Resources Repository [AlzPED] Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice
